We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Cellectricon Launches Outsourced Discovery Services to Enhance Research into Cytoskeletal Disturbances

Product News   Apr 04, 2013

 
Cellectricon Launches Outsourced Discovery Services to Enhance Research into Cytoskeletal Disturbances
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

Byondis’ Investigational Antibody-Drug Conjugate Selected for Trial in Early-Stage Breast Cancer

Product News

Byondis has announced that Quantum Leap selected the company’s investigational antibody-drug conjugate SYD985 for a new investigational treatment arm in its ongoing I-SPY 2 TRIAL™ for neoadjuvant treatment of locally advanced breast cancer.

READ MORE

Rentschler Biopharma and Vetter Team Up to Optimize Time-To-Market

Product News

Vetter and Rentschler Biopharma have announced their strategic collaboration to enhance their services and offer complementary skills and experience along the biopharmaceutical value chain.

READ MORE

Freyr Launches COVID-19 Web Platform with Regulatory Information for Manufacturers

Product News

Freyr has announced the launch of a web platform for COVID-19 driven with real-time information for manufacturers to help them get to market and support them in emergency use authorizations with global regulatory authorities.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE